SAB Biotherapeutics, Inc. (SABS)
NASDAQ: SABS · IEX Real-Time Price · USD
4.100
+0.050 (1.23%)
May 3, 2024, 10:24 AM EDT - Market open
SAB Biotherapeutics Revenue
In the year 2023, SAB Biotherapeutics had annual revenue of $2.24M, a decrease of -90.63%. Revenue in the quarter ending December 31, 2023 was $305.01K, a -85.88% decrease year-over-year.
Revenue (ttm)
$2.24M
Revenue Growth
-90.63%
P/S Ratio
16.56
Revenue / Employee
$39,281
Employees
57
Market Cap
37.82M USD
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 2.24M | -21.67M | -90.63% |
Dec 31, 2022 | 23.90M | -36.97M | -60.73% |
Dec 31, 2021 | 60.88M | 5.64M | 10.21% |
Dec 31, 2020 | 55.24M | 51.80M | 1,504.91% |
Dec 31, 2019 | 3.44M | - | - |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Owlet | 54.01M |
ImmuCell | 17.47M |
iCAD, Inc. | 17.32M |
electroCore | 16.03M |
Co-Diagnostics | 6.81M |
Marker Therapeutics | 3.31M |
SABS News
- 17 days ago - SAB Biotherapeutics Provides SAB-142 Trial Update - GlobeNewsWire
- 25 days ago - SAB Biotherapeutics to Present at INNODIA Annual Meeting - GlobeNewsWire
- 4 weeks ago - SAB Biotherapeutics to Present at the Needham Virtual Healthcare Conference - GlobeNewsWire
- 5 weeks ago - SAB Biotherapeutics Reports Full Year 2023 Operating and Financial Results - GlobeNewsWire
- 5 weeks ago - SAB Biotherapeutics Announces Clinical Partnership with Naval Medical Research Center to Advance Potential Influenza Treatment - GlobeNewsWire
- 2 months ago - SAB Biotherapeutics to Present at the BIO CEO & Investor Conference - GlobeNewsWire
- 3 months ago - SAB Biotherapeutics to Present at the Oppenheimer 34th Annual Healthcare Life Sciences Conference - GlobeNewsWire
- 3 months ago - SAB Biotherapeutics Announces Executive Leadership Change - GlobeNewsWire